Effect of paricalcitol on mineral bone metabolism in kidney transplant recipients with secondary hyperparathyroidism
Introduction: Secondary hyperparathyroidism is highly prevalent in kidney transplant recipients, and commonly results in hypercalcaemia; an association to osteopenia and bone fractures has also been observed. Paricalcitol has proved effective to control secondary hyperparathyroidism in chronic kidne...
Main Authors: | Francisco José Borrego Utiel, Juan Antonio Bravo Soto, María José Merino Pérez, Isabel González Carmelo, Verónica López Jiménez, Teresa García Álvarez, Yelenei Acosta Martínez, María Auxiliadora Mazuecos Blanca |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-07-01
|
Series: | Nefrología (English Edition) |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2013251415000802 |
Similar Items
-
Efecto de paricalcitol sobre el metabolismo mineralóseo en pacientes trasplantados renales con hiperparatiroidismo secundario
by: Francisco José Borrego Utiel, et al.
Published: (2015-07-01) -
Three Therapeutic Strategies: Cinacalcet, Paricalcitol or Both in Secondary Hyperparathyroidism Treatment in Hemodialysed Patients During 1-Year Observational Study—A Comparison
by: Jacek Zawierucha, et al.
Published: (2019-02-01) -
Cost-effectiveness analysis of cinacalcet vs. paricalcitol in the treatment of hyperparathyroidism secondary to chronic kidney disease
by: Daniela Ponce, et al.
Published: (2023-04-01) -
Paricalcitol Versus Calcifediol for Treating Hyperparathyroidism in Kidney Transplant Recipients
by: Josep M. Cruzado, et al.
Published: (2018-01-01) -
Cost-effectiveness analysis of intravenous paricalcitol vs. oral calcitriol in the treatment of hyperparathyroidism secondary to chronic kidney disease
by: Marilia Mastrocolla de Almeida Cardoso, et al.
Published: (2022-08-01)